PLACES (Population Level Analysis and Community Estimates) is an expansion of the original 500 Cities project and is a collaboration between the Centers for Disease Control and Prevention (CDC), the Robert Wood Johnson Foundation, and the CDC Foundation. The original 500 Cities Project provided city- and census tract-level estimates for the 500 largest US cities. PLACES extends these estimates to all counties, places (incorporated and census designated places), census tracts, and ZIP Code Tabulation Areas (ZCTA) across the United States. This service includes 29 measures for chronic disease related health outcomes (13), prevention measures (9), health risk behaviors (4), and health status (3). Data were provided by CDC Division of Population Health, Epidemiology and Surveillance Branch. Data sources used to generate these measures include Behavioral Risk Factor Surveillance System (BRFSS) data (2020 or 2019), Census Bureau 2010 census population data or annual population estimates for county vintage 2020 or 2019, and American Community Survey (ACS) 2015–2019 estimates, or ACS 2016–2020. The health outcomes include arthritis, current asthma, high blood pressure, cancer (excluding skin cancer), high cholesterol, chronic kidney disease, chronic obstructive pulmonary disease (COPD), coronary heart disease, diagnosed diabetes, depression, obesity, all teeth lost, and stroke. The prevention measures include lack of health insurance, visits to doctor for routine checkup, visits to dentist, taking medicine for high blood pressure control, cholesterol screening, mammography use for women, cervical cancer screening for women, colon cancer screening, and core preventive services use for older adults (men and women). The health risk behaviors include binge drinking, current smoking, physical inactivity, and sleeping less than 7 hours. The health status measures include mental health not good for ≥ 14 days, physical health not good for ≥ 14 days, and poor or fair health. For more information, please visit PLACES or contact places@cdc.gov.

PLACES (Population Level Analysis and Community Estimates) is an expansion of the original 500 Cities project and is a collaboration between the Centers for Disease Control and Prevention (CDC), the Robert Wood Johnson Foundation (RWJF), and the CDC Foundation (CDCF). This service includes 29 measures for chronic disease related health outcomes (13), prevention measures (9), health risk behaviors (4), and health status (3). Data were provided by CDC Division of Population Health, Epidemiology and Surveillance Branch. Data sources used to generate these measures include BRFSS data (2020 or 2019), Census Bureau 2010 census population data or annual population estimates for county vintage 2020 or 2019, and American Community Survey (ACS) 2015-2019 estimates.The health outcomes include arthritis, current asthma, high blood pressure, cancer (excluding skin cancer), high cholesterol, chronic kidney disease, chronic obstructive pulmonary disease (COPD), coronary heart disease, diagnosed diabetes, depression, obesity, all teeth lost, and stroke.The prevention measures include lack of health insurance, visits to doctor for routine checkup, visits to dentist, taking medicine for high blood pressure control, cholesterol screening, mammography use for women, cervical cancer screening for women, colon cancer screening, and core preventive services use for older adults (men and women).The health risk behaviors include binge drinking, current smoking, physical inactivity, and sleeping less than 7 hours.The health status measures include mental health not good for ≥14 days, physical health not good for ≥14 days, and fair or poor health. For more information, please visit https://www.cdc.gov/places or contact places@cdc.gov.

In the period from 2019 to 2021, around 65 percent of heterosexual and lesbian women in the United States reported following breast cancer screening guidelines from the American Cancer Society. This means receiving a mammogram within the past year for women aged 45 to 54 years, and in the past two years for those aged 55 years and older. Screening for cancer involves checking the body for cancer before symptoms show, with the CDC supporting cancer screening for breast, cervical, colorectal, and lung cancers. Prostate cancer screenings Prostate cancer screening rates in the United States were lower compared to other cancers in 2019-2021. At that time, only 37 percent of heterosexual men aged 50 years and older who had not been diagnosed with prostate cancer reported having a prostate specific antigen test within the past year. This rate was higher among gay men with 44 percent, but lower among bisexual men with just 25 percent. Prostate cancer is by far the most common cancer type among men, with an estimated 299,010 new cases in 2024. Fortunately, survival rates for prostate cancer are high, with around 98 percent of men surviving five years after diagnosis. However, the chances of survival increase the sooner the cancer is discovered, highlighting the importance of screening. Colorectal screenings The United States Preventative Services Task Force recommends colorectal cancer screenings for adults aged 45 to 75, and the decision for screenings for those aged 76 to 85 to be made on an individual basis. In 2022, the states with the highest colon cancer screening rates among those aged 50 to 75 years were Connecticut, Rhode Island, and Massachusetts. Wyoming and New Mexico had the lowest colon cancer screening rates at that time, with just 64 percent. Colorectal cancer is one of the deadliest cancer types in the United States, causing an estimated 28,700 deaths among men in 2024, and 24,310 among women.

PLACES (Population Level Analysis and Community Estimates) is an expansion of the original 500 Cities project and is a collaboration between the Centers for Disease Control and Prevention (CDC), the Robert Wood Johnson Foundation (RWJF), and the CDC Foundation (CDCF). This service includes 29 measures for chronic disease related health outcomes (13), prevention measures (9), health risk behaviors (4), and health status (3). Data were provided by CDC Division of Population Health, Epidemiology and Surveillance Branch. Data sources used to generate these measures include BRFSS data (2020 or 2019), Census Bureau 2010 census population data or annual population estimates for county vintage 2020 or 2019, and American Community Survey (ACS) 2015-2019 estimates.The health outcomes include arthritis, current asthma, high blood pressure, cancer (excluding skin cancer), high cholesterol, chronic kidney disease, chronic obstructive pulmonary disease (COPD), coronary heart disease, diagnosed diabetes, depression, obesity, all teeth lost, and stroke.The prevention measures include lack of health insurance, visits to doctor for routine checkup, visits to dentist, taking medicine for high blood pressure control, cholesterol screening, mammography use for women, cervical cancer screening for women, colon cancer screening, and core preventive services use for older adults (men and women).The health risk behaviors include binge drinking, current smoking, physical inactivity, and sleeping less than 7 hours.The health status measures include mental health not good for ≥14 days, physical health not good for ≥14 days, and fair or poor health. For more information, please visit https://www.cdc.gov/places or contact places@cdc.gov.

According to Cognitive Market Research , the global Targeted Cancer Drugs Market size will be XX million by 2033, whereas its compound annual growth rate (CAGR) will be XX% from 2025 to 2033. • North America held the largest share of the global Targeted Cancer Drugs market around XX% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of XX% from 2025 to 2033. • Asia Pacific held a market share of around XX% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of XX% from 2025 to 2033. • Europe accounted for a share of over XX% of the global market size of USD XX million. • The Latin American market is around XX% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of XX% from 2025 to 2033. • Middle East and Africa held the major market of around XX% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of XX% from 2025 to 2033. Market Dynamics of the Targeted Cancer Drugs Market

Key Drivers of the Targeted Cancer Drugs Market

Rising incidence of cancer enhances the targeted cancer drugs market growth

Tobacco use, high body mass index, alcohol usage, low intake of fruits and vegetables, and lack of physical activity are responsible for about one-third of cancer-related risk. Furthermore, one significant risk factor for lung cancer is air pollution. About 30% of cancer cases in low- and lower-middle-income nations are caused by diseases that cause cancer, such as hepatitis and the human papillomavirus (HPV). How frequently a cancer arises (incidence) and how long people typically live after being diagnosed (survival) are the two factors that determine cancer prevalence. This indicates that the most prevalent malignancies with the longest survival have the highest prevalence counts. Compared to a less common cancer with a longer survival, a common cancer with a shorter survival may have a lower prevalence count. For instance, according to the American Cancer Society 2023, non-Hodgkin lymphoma, a less common cancer, has a higher prevalence rate than lung cancer, despite lung cancer being one of the most common malignancies in the US. There are more persons living after a diagnosis of non-Hodgkin lymphoma than after a diagnostic of lung cancer because those with non-Hodgkin lymphoma have a higher chance of surviving longer than those with lung cancer. There were 1,777,566 new cases of cancer reported in the US in 2021. An estimated 608,366 Americans lost their lives to cancer in 2022. https://www.cdc.gov/cancer/data/index.html In the twenty-first century, cancer is a significant social, public health, and economic issue, accounting for about one in six fatalities (16.8%) and one in four deaths (22.8%) from noncommunicable diseases (NCDs) globally. Three out of ten premature deaths worldwide are caused by NCDs (30.3% in people aged 30 to 69), and in 177 out of 183 nations, it ranks among the top three causes of death for this age group. Apart from being a significant hindrance to extending life expectancy, cancer is linked to significant societal and macroeconomic expenses, which differ in extent depending on the type of cancer, location, and gender. For instance, according to International Agency for Research on Cancer in 2022, there were about 20 million new cases of cancer, including nonmelanoma skin cancers (NMSCs), and 9.7 million cancer-related deaths. According to estimates, one in five men and women will get cancer at some point in their lives, while one in nine men and one in twelve women will pass away from the disease. With about 2.5 million new cases, or one in eight cancers worldwide (12.4% of all cancers), lung cancer was the most commonly diagnosed cancer in 2022. It was followed by stomach (4.9%), colorectum (9.6%), prostate (7.3%), and female breast (11.6%) cancers. With an anticipated 1.8 million deaths (18.7%), lung cancer was also the most common cause of cancer-related mortality. Colorectal (9.3%), liver (7.8%), female breast (6.9%), and stomach (6.8%) cancers were next in line. The two most common cancers in both men and women were lung and breast cancer. https://acsjournals.onlinelibrary.wile...

The leading causes of death in the United States have changed significantly from the year 1900 to the present. Leading causes of death in 1900, such as tuberculosis, gastrointestinal infections, and diphtheria have seen huge decreases in death rates and are no longer among the leading causes of death in the United States. However, other diseases such as heart disease and cancer have seen increased death rates. Vaccinations One major factor contributing to the decrease in death rates for many diseases since the year 1900 is the introduction of vaccinations. The decrease seen in the rates of death due to pneumonia and influenza is a prime example of this. In 1900, pneumonia and influenza were the leading causes of death, with around *** deaths per 100,000 population. However, in 2023 pneumonia and influenza were not even among the ten leading causes of death. Cancer One disease that has seen a large increase in death rates since 1900 is cancer. Cancer currently accounts for almost ** percent of all deaths in the United States, with death rates among men higher than those for women. The deadliest form of cancer for both men and women is cancer of the lung and bronchus. Some of the most common avoidable risk factors for cancer include smoking, drinking alcohol, sun exposure, and obesity.

The leading causes of death among Black residents in the United States in 2022 included diseases of the heart, cancer, unintentional injuries, and stroke. The leading causes of death for African Americans generally reflects the leading causes of death for the entire United States population. However, a major exception is that death from assault or homicide is the seventh leading cause of death among African Americans, but is not among the ten leading causes for the general population. Homicide among African Americans The homicide rate among African Americans has been higher than that of other races and ethnicities for many years. In 2023, around 9,284 Black people were murdered in the United States, compared to 7,289 white people. A majority of these homicides are committed with firearms, which are easily accessible in the United States. In 2022, around 14,189 Black people died by firearms. However, suicide deaths account for over half of all deaths from firearms in the United States. Cancer disparities There are also major disparities in access to health care and the impact of various diseases. For example, the incidence rate of cancer among African American males is the greatest among all ethnicities and races. Furthermore, although the incidence rate of cancer is lower among African American women than it is among white women, cancer death rates are still higher among African American women.

According to Cognitive Market Research, the Global Gynaecological Cancer Drugs Market Size will be USD XX Billion in 2023 and is set to achieve a market size of USD XX Billion by the end of 2031 growing at a CAGR of XX% from 2024 to 2031.

• The global gynecological cancer drugs market will expand significantly by XX% CAGR between 2024 and 2031. • The cervical cancer type segment accounts for the largest market share and is anticipated to a healthy growth over the approaching years. • The alkylating agent cancer drugs had a market share of about XX% in 2022. • The hospitals sector holds the largest share and is expected to grow in the coming years as well. • chemotherapy treatment is the markets largest contributor and is anticipated to expand at a CAGR of XX% during the projected period. • North america region dominated the market and accounted for the highest revenue of XX% in 2022 and it is projected that it will grow at a CAGR of XX% in the future. Market Dynamics: Gynecological Cancer Drugs

Key Drivers-

Growing awareness about women's health drives the market for gynecological cancer drugs-

Health issues of women are of great importance in society as they directly impact the fabric of family and society. The number of women diagnosed with gynecological cancer is growing, contributing to the increased demand for treatment options. Healthcare providers and patients are more inclined to adopt these gynecological cancer drugs due to their improved efficacy and reduced side effects. Gynecological cancer is any cancer that occurs in a woman’s reproductive organs. The gynecological cancers begin in different places within a woman’s pelvis. There are various initiatives are taken by regions like Asia Pacific, North America, etc. For instance- WHO’s comprehensive global cancer statistics of the International Agency for Research on Cancer (IARC) state that almost 70 percent of the global burden falls in areas with lower development and also found that in India more than one-fifth of all new cases [3]. India’s National Cancer Control Program has raised the significance of early detection and treatment. (source:http://waocp.com/journal/index.php/apjcc/article/view/410) For instance- to promote knowledge and awareness of cervical and other gynecologic cancers, the FSM Yap Comprehensive Cancer Control program, funded by CDC’s NCCCP, partnered with the Inside Knowledge campaign to provide educational materials to local medical providers and women and facilitate discussions about these materials. (source:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697471/) Furthermore, growing awareness and concern about gynecological cancer leads to improved detection and treatment of gynecological cancer, boosting market expansion.

Rising gynecological diseases driving the gynecological drugs market-

Gynecological cancer mainly including ovarian, cervical, and endometrial cancer, seriously affects the health of women worldwide, contributing considerably to the global cancer burden. gynecological and cervical cancers are the most common gynecological cancers affecting women worldwide and in India. The reasons for more women suffering from gynecological Cancer is due to lack of awareness, early marriage, multiple sexual partners, multiple pregnancies, poor genital hygiene of both men and women, inadequate health care facilities, lack of testing facilities in rural areas, smoking, and the like. Additionally, according to WHO, Globally, cervical cancer is the fourth most common cancer in women, with around 660,000 new cases in 2022. In the same year, about 94% of the 350,000 deaths caused by cervical cancer occurred in low- and middle-income countries. (source:https://www.who.int/news-room/fact-sheets/detail/cervical-cancer?gad_source=1&gclid=Cj0KCQjwkdO0BhDxARIsANkNcre9nq_h0j99DHFaEjjEpFYUAurmQullODEy-s3uNC5zbG1J_DT7fXAaAsq_EALw_wcB) Hence, the increasing gynecological diseases increase the demand for medical-based treatment and boost the market for gynecological drugs.

Restraint-

Side effects of drugs are the major restraint for gynecological cancer drugs-

During gynecological cancer therapy, certain normal cells may be negatively impacted by the medications, resulting in a variety of side effects. As a res...

PLACES (Population Level Analysis and Community Estimates) is an expansion of the original 500 Cities project and is a collaboration between the Centers for Disease Control and Prevention (CDC), the Robert Wood Johnson Foundation (RWJF), and the CDC Foundation (CDCF). This service includes 29 measures for chronic disease related health outcomes (13), prevention measures (9), health risk behaviors (4), and health status (3). Data were provided by CDC Division of Population Health, Epidemiology and Surveillance Branch. Data sources used to generate these measures include BRFSS data (2020 or 2019), Census Bureau 2010 census population data or annual population estimates for county vintage 2020 or 2019, and American Community Survey (ACS) 2015-2019 estimates.The health outcomes include arthritis, current asthma, high blood pressure, cancer (excluding skin cancer), high cholesterol, chronic kidney disease, chronic obstructive pulmonary disease (COPD), coronary heart disease, diagnosed diabetes, depression, obesity, all teeth lost, and stroke.The prevention measures include lack of health insurance, visits to doctor for routine checkup, visits to dentist, taking medicine for high blood pressure control, cholesterol screening, mammography use for women, cervical cancer screening for women, colon cancer screening, and core preventive services use for older adults (men and women).The health risk behaviors include binge drinking, current smoking, physical inactivity, and sleeping less than 7 hours.The health status measures include mental health not good for ≥14 days, physical health not good for ≥14 days, and fair or poor health. For more information, please visit https://www.cdc.gov/places or contact places@cdc.gov.

As of 2022, around **** million adults in the United States were current cigarette smokers. Although this figure is still high, it is significantly lower compared to previous years. For example, in 2011, there were almost ** million smokers in the United States. Smoking demographics in the U.S. Although smoking in the U.S. has decreased greatly over the past few decades, it is still more common among certain demographics than others. For example, men are more likely to be current cigarette smokers than women, with ** percent of men smoking in 2021, compared to ** percent of women. Furthermore, non-Hispanic whites and non-Hispanic Blacks smoke at higher rates than Hispanics and non-Hispanic Asians, with almost ** percent of non-Hispanic whites smoking in 2022, compared to just under **** percent of non-Hispanic Asians. Certain regions and states also have a higher prevalence of smoking than others, with around ** percent of adults in West Virginia considered current smokers, compared to just *** percent in Utah. The health impacts of smoking The decrease in smoking rates in the United States over the past decades is due to many factors, including policies and regulations limiting cigarette advertising, promotion, and sales, price increases for cigarettes, and widespread awareness among the public of the dangers of smoking. According to the CDC, those who smoke are *** to **** times more likely to develop coronary heart disease and stroke and around ** times more likely to develop lung cancer than nonsmokers. In fact, it is estimated that around ** percent of lung cancer deaths in the United States can be attributed to cigarette smoking, as well as ** percent of larynx cancer deaths. Cigarette smokers are also much more likely to develop chronic obstructive pulmonary disease (COPD), with around ** percent of current smokers in the U.S. living with COPD in 2021, compared to just ***** percent of those who had never smoked.

PLACES (Population Level Analysis and Community Estimates) is an expansion of the original 500 Cities project and is a collaboration between the Centers for Disease Control and Prevention (CDC), the Robert Wood Johnson Foundation (RWJF), and the CDC Foundation (CDCF). This service includes 29 measures for chronic disease related health outcomes (13), prevention measures (9), health risk behaviors (4), and health status (3). Data were provided by CDC Division of Population Health, Epidemiology and Surveillance Branch. Data sources used to generate these measures include BRFSS data (2020 or 2019), Census Bureau 2010 census population data or annual population estimates for county vintage 2020 or 2019, and American Community Survey (ACS) 2015-2019 estimates.The health outcomes include arthritis, current asthma, high blood pressure, cancer (excluding skin cancer), high cholesterol, chronic kidney disease, chronic obstructive pulmonary disease (COPD), coronary heart disease, diagnosed diabetes, depression, obesity, all teeth lost, and stroke.The prevention measures include lack of health insurance, visits to doctor for routine checkup, visits to dentist, taking medicine for high blood pressure control, cholesterol screening, mammography use for women, cervical cancer screening for women, colon cancer screening, and core preventive services use for older adults (men and women).The health risk behaviors include binge drinking, current smoking, physical inactivity, and sleeping less than 7 hours.The health status measures include mental health not good for ≥14 days, physical health not good for ≥14 days, and fair or poor health. For more information, please visit https://www.cdc.gov/places or contact places@cdc.gov.

PLACES (Population Level Analysis and Community Estimates) is an expansion of the original 500 Cities project and is a collaboration between the Centers for Disease Control and Prevention (CDC), the Robert Wood Johnson Foundation, and the CDC Foundation. The original 500 Cities Project provided city- and census tract-level estimates for the 500 largest US cities. PLACES extends these estimates to all counties, places (incorporated and census designated places), census tracts, and ZIP Code Tabulation Areas (ZCTA) across the United States. This service includes 29 measures for chronic disease related health outcomes (13), prevention measures (9), health risk behaviors (4), and health status (3). Data were provided by CDC Division of Population Health, Epidemiology and Surveillance Branch. Data sources used to generate these measures include the Behavioral Risk Factor Surveillance System (BRFSS) data (2019 or 2018), Census Bureau 2010 census population data or annual population estimates for county vintage 2019 or 2018, and American Community Survey 2015-2019 or 2014-2018 estimates. The health outcomes include arthritis, current asthma, high blood pressure, cancer (excluding skin cancer), high cholesterol, chronic kidney disease, chronic obstructive pulmonary disease (COPD), coronary heart disease, diagnosed diabetes, depression, obesity, all teeth lost, and stroke. The prevention measures include lack of health insurance, visits to doctor for routine checkup, visits to dentist, taking medicine for high blood pressure control, cholesterol screening, mammography use for women, cervical cancer screening for women, colon cancer screening, and core preventive services use for older adults (men and women). The health risk behaviors include binge drinking, current smoking, physical inactivity, and sleeping less than 7 hours. The health status measures include mental health not good for ≥14 days, physical health not good for ≥14 days, and fair or poor health. For more information, please visit https://www.cdc.gov/places or contact places@cdc.gov.

Chronic Disease Prevalence and Other Risk Factors from Behavioral Risk Factor Surveillance Survey (BRFSS) 2018 or 2017, Census Bureau 2010 census population or annual population estimates for county 2018 or 2017, and American Community Survey (ACS) 2014-2018 or 2013-2017Health Outcomes: arthritis, current asthma, high blood pressure, cancer (excluding skin cancer), high cholesterol, chronic kidney disease, chronic obstructive pulmonary disease (COPD), coronary heart disease, diagnosed diabetes, mental health not good for >=14 days, physical health not good for >=14 days, all teeth lost and strokePreventive Service Utilization: lack of health insurance, visits to doctor for routine checkup, visits to dentist, taking medicine for high blood pressure control, cholesterol screening, mammography use for women, cervical cancer screening for women, colon cancer screening, and core preventive services use for older adults (men and women)Unhealthy Behavior Risk Factors: binge drinking, current smoking, obesity, physical inactivity, and sleeping less than 7 hoursSee original CDC Project map for PLACES (Population Level Analysis and Community Estimates) here.PLACES expands the original 500 Cities project and is a collaboration between the CDC, the Robert Wood Johnson Foundation (RWJF), and the CDC Foundation (CDCF)